Prevention of etomidate-induced myoclonus during anesthetic induction by pretreatment with dexmedetomidine
Braz. j. med. biol. res
;
48(2): 186-190, 02/2015. tab
Article
Dans Anglais
| LILACS
| ID: lil-735855
ABSTRACT
Myoclonus induced by etomidate during induction of general anesthesia is undesirable. This study evaluated the effect of dexmedetomidine (DEX) pretreatment on the incidence and severity of etomidate-induced myoclonus. Ninety patients undergoing elective surgical procedures were randomly allocated to three groups (n=30 each) for intravenous administration of 10 mL isotonic saline (group I), 0.5 µg/kg DEX in 10 mL isotonic saline (group II), or 1.0 µg/kg DEX in 10 mL isotonic saline (group III) over 10 min. All groups subsequently received 0.3 mg/kg etomidate by intravenous push injection. The incidence and severity of myoclonus were recorded for 1 min after etomidate administration and the incidence of cardiovascular adverse events that occurred between the administration of the DEX infusion and 1 min after tracheal intubation was recorded. The incidence of myoclonus was significantly reduced in groups II and III (30.0 and 36.7%), compared with group I (63.3%). The incidence of severe sinus bradycardia was significantly increased in group III compared with group I (P<0.05), but there was no significant difference in heart rate in groups I and II. There were no significant differences in the incidence of low blood pressure among the 3 groups. Pretreatment with 0.5 and 1.0 µg/kg DEX significantly reduced the incidence of etomidate-induced myoclonus during anesthetic induction; however, 0.5 µg/kg DEX is recommended because it had fewer side effects.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Bradycardie
/
Anesthésiques généraux
/
Dexmédétomidine
/
Étomidate
/
Hypnotiques et sédatifs
/
Myoclonie
Type d'étude:
Essai clinique contrôlé
/
Etude d'incidence
/
Étude pronostique
Limites du sujet:
Adulte
/
Femelle
/
Humains
/
Mâle
langue:
Anglais
Texte intégral:
Braz. j. med. biol. res
Thème du journal:
Biologie
/
Médicament
Année:
2015
Type:
Article
/
descriptif de projet
Pays d'affiliation:
Chine
Institution/Pays d'affiliation:
The First People's Hospital of Lianyungang/CN
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS